Biological Assembly 1  

 3D View: Structure | Electron Density

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Hetero 2-mer - A1B 

Biological assembly 1 assigned by authors.

Macromolecule Content

• Total Structure Weight: 57.41 kDa 
• Atom Count: 3719 
• Residue Count: 470 
• Unique protein chains: 2

6OQ6

Structure of the pore forming fragment of Clostridium difficile toxin B in complex with VHH 5D

• DOI: 10.2210/pdb6OQ6/pdb

• Classification: TOXIN
• Organism(s): Clostridioides difficile, Camelidae
• Expression System: Escherichia coli
• Mutation(s): No 


• Deposited: 2019-04-25 Released: 2019-07-10 
• Deposition Author(s): Chen, P., Lam, K., Jin, R.
• Funding Organization(s): National Institutes of Health/National Center for Research Resources (NIH/NCRR)

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.97 Å
• R-Value Free: 0.274 
• R-Value Work: 0.259 
• R-Value Observed: 0.260 

Literature

Structure of the full-length Clostridium difficile toxin B.

Chen, P., Lam, K.H., Liu, Z., Mindlin, F.A., Chen, B., Gutierrez, C.B., Huang, L., Zhang, Y., Hamza, T., Feng, H., Matsui, T., Bowen, M.E., Perry, K., Jin, R.

(2019) Nat Struct Mol Biol 26: 712-719

• PubMed: 31308519 
• DOI: 10.1038/s41594-019-0268-0
• Structures With Same Primary Citation


• PubMed Abstract: 
  

Clostridium difficile is an opportunistic pathogen that establishes in the colon when the gut microbiota are disrupted by antibiotics or disease. C. difficile infection (CDI) is largely caused by two virulence factors, TcdA and TcdB. Here, we report a 3.87-Å-resolution crystal structure of TcdB holotoxin that captures a unique conformation of TcdB at endosomal pH. Complementary biophysical studies suggest that the C-terminal combined repetitive oligopeptides (CROPs) domain of TcdB is dynamic and can sample open and closed conformations that may facilitate modulation of TcdB activity in response to environmental and cellular cues during intoxication. Furthermore, we report three crystal structures of TcdB-antibody complexes that reveal how antibodies could specifically inhibit the activities of individual TcdB domains. Our studies provide novel insight into the structure and function of TcdB holotoxin and identify intrinsic vulnerabilities that could be exploited to develop new therapeutics and vaccines for the treatment of CDI.

---

Organizational Affiliation: 

Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA. [e-mail].

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
Toxin B	A	363	Clostridioides difficile	Mutation(s): 0  Gene Names: tcdB, SAMEA708418_03270 EC: 2.4.1
Find proteins for M4NKV9 (Clostridioides difficile) Go to UniProtKB:  M4NKV9

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details
5D	D	153	Camelidae	Mutation(s): 0
Protein Feature View is not available: No corresponding UniProt sequence found.

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.97 Å
• R-Value Free: 0.274 
• R-Value Work: 0.259 
• R-Value Observed: 0.260 
• Space Group: P 6₁ 2 2

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 169.82	α = 90
b = 169.82	β = 90
c = 79.12	γ = 120

Software Package:

Software Name	Purpose
REFMAC	refinement
XDS	data reduction
XDS	data scaling
PHASER	phasing

Structure Validation

Entry History & Funding Information

Deposition Data

• Deposited Date: 2019-04-25 
• Released Date: 2019-07-10 
Deposition Author(s): Chen, P., Lam, K., Jin, R.

---

Funding Organization	Location	Grant Number
National Institutes of Health/National Center for Research Resources (NIH/NCRR)	United States	--

Revision History 

• Version 1.0: 2019-07-10
  Type: Initial release
  
• Version 1.1: 2019-07-31
  Changes: Data collection, Database references
• Version 1.2: 2019-08-21
  Changes: Data collection, Database references
• Version 1.3: 2019-12-04
  Changes: Author supporting evidence